North East and North Cumbria
ICS Formulary
 
back
5 Infections
05-02-01 Triazole antifungals

Fluconazole Oral Preparations
Formulary
  • Capsules: 50mg, 150mg, 200mg
  • Oral solution: 50mg/5ml, 200mg/5ml 

Green View adult BNF  View SPC online  View childrens BNF
Itraconazole Oral Preparations
Formulary
  • 100mg capsules 
  • 50mg in 5ml oral solution 

Green plus View adult BNF  View SPC online  View childrens BNF
Fluconazole Infusion
Formulary
  • IV infusion: 50mg/25ml, 200mg/100ml

Red View adult BNF  View SPC online  View childrens BNF
Isavuconazole Cresemba®
Formulary
  • Approved for use in line with licensed indications and specifically in solid organ transplant and bone marrow transplant recipients.

Red View adult BNF  View SPC online  View childrens BNF  HCD
Itraconazole Infusion
Formulary
  • 250mg in 25ml injection for IV infusion 

Red View adult BNF  View SPC online  View childrens BNF
Posaconazole  Noxafil®
Formulary
  • Approved for the prevention of invasive fungal infection in immunocompromised patients in whom there is a specific risk of aspergillus infection or where fluconazole and itraconazole are not tolerated or are unlikely to be sufficiently effective (largely for secondary prevention).
  • Approved for patients with invasive fungal infections that are not responding to other treatments or where they are not tolerated (largely in place of liposomal amphotericin/ voriconazole).

Red View adult BNF  View SPC online  View childrens BNF  HCD
Voriconazole
Formulary
  • Green plus for the treatment of non-invasive fungal infections (Off-label indication) using the 100mg tablets ONLY. Can be initiated in primary care on the basis of C&S results / microbiology advice in patients who are not under secondary care.
Link  MHRA Safety Alert (May 2014): Voriconazole: reminder of liver toxicity, phototoxicity and squamous cell carcinoma

Red View adult BNF  View SPC online  View childrens BNF